Traders should now look for long-biased trades in JCP as long as it's trending above $17.93 with strong upside volume flows. I would consider any upside volume day that registers near or above 9.04 million shares as bullish. If JCP can maintain that trend, then this stock has the chance to see a powerful bounce back towards its 50-day moving average of $23.10.
This is a worldwide industrial company comprised of two strategic platforms: Process & Motion Control and Water Management. This stock is trading up 2.5% at $21.21 in recent trading.
Today's Volume: 480,000Average Volume: 249,239 Volume % Change: 206% Shares of RXN are trending up today after the company reported a net sales increase of 11% from the prior year second quarter to $500 million. From a technical perspective, RXN is bouncing higher here right off some near-term support at $20.50 with above-average volume. This stock has been uptrending very strong for the last two months, with shares moving from a low of $16.38 to its recent high of $21.50. During that uptrend, shares of RXN have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed RXN within range of triggering a major breakout trade. That trade will hit once the stock manages to take out some past overhead resistance levels at $21.58 to $22.83 with high volume. Traders should now look for long-biased trades in RXN as long as it's trending above $21.58, and then once it sustains a move or close above $22.60 to $22.83 with volume that hits near or above 249,239 shares. If that breakout triggers soon, then RXN will enter new all-time high territory once it takes out $22.83. Some possible upside targets off that move are $25 to $28 in the near future. Sarepta Therapeutics (SRPT - Get Report) This company is focused on developing RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. This stock is trading up 3% at $29.62 in recent trading.